Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07384754 · ClinicalTrials.gov registry record · NA
Foot Strengthening to Improve Balance and Gait in Older Adults
A NA study of Control Condition and Minimalist Footwear, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT07384754: Recruiting NA study of Control Condition and Minimalist Footwear, sponsored by Indiana University.
NCT07384754 is a NA study of Control Condition and Minimalist Footwear that is actively recruiting participants, run by Indiana University. The registered enrollment target is 160 participants, below the 12,055-participant average among 5 other Control Condition trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07384754, a NA study of Control Condition and Minimalist Footwear, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn whether different foot-strengthening strategies can improve foot strength, balance, walking ability, and fall-related outcomes in middle-aged and older adults (ages 45-85 years). The main questions it aims to answer are: * Does foot strength change from baseline after an 8-week foot-strengthening intervention? * Do balance, gait, and physical function improve following different foot-strengthening approaches? Researchers will compare minimalist footwear use, a foot exercise program, a foot-strengthening device (ToePro), and no intervention to see if these interventions lead to greater improvements in foot strength, balance, gait, and fall-related outcomes than no intervention. Participants will: * Complete baseline and post-intervention laboratory testing of foot strength, balance, physical function, and walking gait * Perform foot strengthening exercises or wear minimalist footwear (if applicable) five days/week for eight weeks * Complete daily logs to record intervention compliance
Primary Outcome
Change in maximal hallux (big toe) flexion strength assessed using a standardized hallux curl test (i.e., flexion at the metatarsal interphalangeal joints) with a dynamometer. Participants perform brief maximal voluntary contractions, and peak force output is recorded. Higher values indicate greater hallux curl strength.
Conditions Studied
Interventions
- DEVICE Minimalist footwear
- BEHAVIORAL Foot strengthening exercises
- DEVICE ToePro foot strengthening device
Study Locations (1)
Indiana
- School of Public Health-Bloomington - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT07384754 shows while recruiting
NCT07384754 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 12,055-participant average among 5 other Control Condition trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Control Condition appearing as the primary indexed condition, and to 3 interventions - of which Minimalist footwear is the first listed.
NCT07384754 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07384754 about?
NCT07384754 is a clinical study titled "Foot Strengthening to Improve Balance and Gait in Older Adults". The goal of this clinical trial is to learn whether different foot-strengthening strategies can improve foot strength, balance, walking ability, and fall-related outcomes in middle-aged and older adults (ages 45-85 years). The main questions it aims to answer are: * Does foot strength change from ...
What is the current status of trial NCT07384754?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2026-01-01. Estimated completion is 2027-06-30.
What conditions does trial NCT07384754 study?
This clinical trial studies the following conditions: Control Condition, Minimalist Footwear, Traditional Foot Exercise Program, Foot Strengthening Device (ToePro).
What interventions are being tested in trial NCT07384754?
The interventions under investigation include: Minimalist footwear (DEVICE), Foot strengthening exercises (BEHAVIORAL), ToePro foot strengthening device (DEVICE).
Who is sponsoring clinical trial NCT07384754?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07384754 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Control Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise and Protein Efficiency in T2D
RECRUITING · NA
-
Effect of Exercise and Heat Stress on Acute Cardiometabolic Adaptations in Healthy Young Adults
RECRUITING · NA
-
Disrupted Connections: The Impact of Acute Stress on Memory Integration
ACTIVE NOT RECRUITING · NA
-
How v. How and Why Nudges and Rewards
COMPLETED · NA
-
Physical Exercise to Reduce Anxiety in Underserved Children With ASD
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI